ACAN and arthritic joint disease: Similarly, transgenic mice with a knock-in mutation of aggrecan preventing ‘aggrecanase’ cleavage of the Glu373 ~ Ala374 bond also develop less severe OA in the surgical OA and antigen-induced arthritis models [18].